| scholarly article | Q13442814 |
| P2093 | author name string | Mohsin Kazi | |
| Fars Kaed Alanazi | |||
| Majed Alwadei | |||
| P2860 | cites work | NMR study of the solution structure of curcumin | Q31102198 |
| The effect of thymoquinone on intractable pediatric seizures (pilot study). | Q34152132 | ||
| Pharmacological and toxicological properties of Nigella sativa | Q34193800 | ||
| Preparation and evaluation of self-microemulsifying drug delivery system of oridonin | Q34744529 | ||
| Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion | Q35821890 | ||
| Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from Capra hircus and Its Admixtures with Melon Oil for the Delivery of Indomethacin | Q36112240 | ||
| Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. | Q36308578 | ||
| Molecular understanding and modern application of traditional medicines: triumphs and trials. | Q36828585 | ||
| Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies | Q36955998 | ||
| Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug | Q37021478 | ||
| Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences. | Q37910902 | ||
| Thymoquinone: potential cure for inflammatory disorders and cancer | Q37946658 | ||
| Stability of nanosuspensions in drug delivery. | Q38129657 | ||
| Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects | Q40563465 | ||
| Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion | Q41809141 | ||
| Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in-vitro assessment | Q41988231 | ||
| Stereoselective disposition of talinolol in man. | Q42163283 | ||
| Potential anticancer activity of turmeric (Curcuma longa). | Q42229848 | ||
| Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin | Q43125418 | ||
| A study on the fate of curcumin in the rat | Q43457309 | ||
| Biodegradable microspheres of curcumin for treatment of inflammation. | Q44261365 | ||
| Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization | Q45182288 | ||
| Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). | Q46427147 | ||
| Formulation design and in vitro physicochemical characterization of surface modified self-nanoemulsifying formulations (SNEFs) of gentamicin | Q47892813 | ||
| Biotransformation of curcumin through reduction and glucuronidation in mice | Q48249491 | ||
| Antioxidant activity of curcumin and related compounds | Q48373542 | ||
| Multi-Layer Self-Nanoemulsifying Pellets: an Innovative Drug Delivery System for the Poorly Water-Soluble Drug Cinnarizine. | Q52562255 | ||
| Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). | Q53527841 | ||
| The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat | Q67425679 | ||
| Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation | Q68935726 | ||
| Metabolism of curcumin--studies with [3H]curcumin | Q71109075 | ||
| Absorption and tissue distribution of curcumin in rats | Q71343563 | ||
| Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture | Q73159969 | ||
| Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment | Q73410566 | ||
| Enhancement of wound healing by curcumin in animals | Q77426656 | ||
| Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs | Q79987953 | ||
| Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME) | Q80809781 | ||
| In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine | Q86822925 | ||
| Dissolution improvement of solid self-emulsifying drug delivery systems of fenofibrate using an inorganic high surface adsorption material | Q86945652 | ||
| Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light | Q87847803 | ||
| Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L | Q93612427 | ||
| P433 | issue | 6 | |
| P921 | main subject | phytochemistry | Q640068 |
| drug delivery | Q1392806 | ||
| P1104 | number of pages | 11 | |
| P304 | page(s) | 866-876 | |
| P577 | publication date | 2019-05-25 | |
| P1433 | published in | Saudi Pharmaceutical Journal | Q15763912 |
| P1476 | title | Novel oral dosage regimen based on self-nanoemulsifying drug delivery systems for codelivery of phytochemicals - Curcumin and thymoquinone | |
| P478 | volume | 27 |
| Q100697607 | Capsaicin loaded solid SNEDDS for enhanced bioavailability and anticancer activity: In-vitro, in-silico, and in-vivo characterization |
| Q92307067 | Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects |
Search more.